144 related articles for article (PubMed ID: 14872339)
21. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer.
Yamane N; Tsujitani S; Makino M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):232-8. PubMed ID: 10202279
[TBL] [Abstract][Full Text] [Related]
22. Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma.
Yoshida R; Morita M; Shoji F; Nakashima Y; Miura N; Yoshinaga K; Koga T; Tokunaga E; Saeki H; Oki E; Oda Y; Maehara Y
Ann Surg Oncol; 2015 Aug; 22(8):2608-14. PubMed ID: 25564163
[TBL] [Abstract][Full Text] [Related]
23. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
25. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus.
Nozoe T; Ezaki T; Kabashima A; Baba H; Maehara Y
Am J Surg; 2005 Jan; 189(1):110-5. PubMed ID: 15701502
[TBL] [Abstract][Full Text] [Related]
26. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma.
Shimada Y; Hashimoto Y; Kan T; Kawamura J; Okumura T; Soma T; Kondo K; Teratani N; Watanabe G; Ino Y; Sakamoto M; Hirohashi S; Imamura M
Oncology; 2004; 67(1):73-80. PubMed ID: 15459499
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of mannose-binding lectin-associated serine protease-2 expression in esophageal squamous cell carcinoma.
Verma A; Matta A; Shukla NK; Deo SV; Gupta SD; Ralhan R
Int J Cancer; 2006 Jun; 118(12):2930-5. PubMed ID: 16395704
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
[TBL] [Abstract][Full Text] [Related]
31. [Relationship of the expression of CD44v6 and paxillin to the prognosis of non-small cell lung carcinoma].
Zuo W; Li H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):484-5. PubMed ID: 12910696
[TBL] [Abstract][Full Text] [Related]
32. Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: prognostic value of CD44v6 score.
Ekici S; Ayhan A; Kendi S; Ozen H
J Urol; 2002 May; 167(5):2037-41. PubMed ID: 11956433
[TBL] [Abstract][Full Text] [Related]
33. TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications.
Sharma R; Sud N; Chattopadhyay TK; Ralhan R
Oncology; 2005; 69(1):10-8. PubMed ID: 16088230
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study.
Hefler LA; Concin N; Mincham D; Thompson J; Swarte NB; van Eijkeren MA; Sie-Go DM; Hammond I; McCartney AJ; Tempfer CB; Speiser P
Cancer; 2002 Jan; 94(1):125-30. PubMed ID: 11815968
[TBL] [Abstract][Full Text] [Related]
35. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
[TBL] [Abstract][Full Text] [Related]
36. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus.
Nozoe T; Korenaga D; Itoh S; Futatsugi M; Maehara Y
J Cancer Res Clin Oncol; 2002 Dec; 128(12):691-6. PubMed ID: 12474056
[TBL] [Abstract][Full Text] [Related]
38. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
[TBL] [Abstract][Full Text] [Related]
39. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
[TBL] [Abstract][Full Text] [Related]
40. [Significance and expression of vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and glioma].
Pang XH; Tian H; Liu ZY; Li SM; Liu ST; Tian GP
Ai Zheng; 2003 Nov; 22(11):1166-9. PubMed ID: 14613645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]